Background: Breast cancer is the most frequent cancer in women and the second leading cause of death among them. Breast lesions were first categorized as benign or cancerous.Objective: was to highlight the role of noninvasive diagnostic breast modalities including mammography, ultrasound, conventional MRI and MRI diffusion imaging in detection and characterization of suspicious breast lesions.Methodology: It was a hospital based cross sectional study done on total number of 50 female patients presented by breast lump or nipple discharge, some of them were referred from surgical department and others from out-patient clinic to the radiology department at Met Ghamr oncology center, after receiving clearance from the institute's ethical council, the study was carried out for two years, from June 2019 to August 2021. Before being included in the trial, all patients provided informed permission. They were subjected for imaging by digital mammography, ultrasonography and MRI mammography. Results:The study revealed that in the evaluation and description of worrisome breast lesions, MRI mammography plays a leading role over digital mammography and ultrasonography. Conclusion:MRI mammography outperformed digital mammography and ultrasonography regarding of sensitivity, specificity, and diagnostic performance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.